chrisvoncsefalvay/vaers-outcomes huggingface dataset:
She got her vaccine at about 6:30, and the bottom of her foot started swelling, then the to of her foot, ankle, tingling of her feet (both), neuropathy pain came back which she hadn't had in a long time.    The spinal stenosis pain came back very strongly and her fibromyalgia pain came back and they were all pretty well managed prior to the vaccine.   She is still having that pain.  She is on a pain management regimen to control her pain prior to the vaccine, and then it has worsened and was scheduled for an epidural spinal shot and not able to get off the Eliquis due to the vaccine and that has been postponed.  She was on Duloxetine for the neuropathy pain and it had been being managed and then all of a sudden that pain has worsened and the medicine she was taking for that did not work anymore.  She went to the ER on 5/5/21, and they gave her Morphine for the pain, and discharged her home with Tramadol.  The 2nd ER visit was on 5/15/21, as when she woke up both of her legs were numb, and could not feel her legs from her ankle to her hip/waste area.  When she opened her eyes she thought she was looking at the side wall and was looking at the ceiling and could not discern where she was, was disoriented and called her doctor and told to go to the ER.   She went to the ER and they finally took it seriously and they suggested that she had inflammation in her system that was causing her other problems to flare up.  She made appointments with her specialists to see where the inflammation was.  She then saw a rheumatologist as when she went to the ER the 2nd time they wanted to put her on steroids and she did not want to be put on it due to her diabetes.  She did have drug-induced lupus at one point from isoniazid.  Her rheumatologist confirmed she did have inflammation on blood work and told her to take the steroids.   The steroids have taken down some of the pain, but not completely.  She did have a lumbar epidural steroid injection yesterday 6/9/21 at L4 bilaterally, which has helped as of today.   She was put on Tramadol after the first ER visit by her pain management doctor and that did not work.  After that she was switched to Hydrocodone which has helped her.    Her cardiologist, rheumatologist and PCP told her that it hit things that impacted her nervous system and that she has inflammation in her system, does not know exactly where it is and it has impacted her system and caused intensity of her spinal stenosis, neuropathy and fibromyalgia.  She is still undergoing treatment for these symptoms.    She was not feeling her neuropathy pain hardly at all prior to the vaccine.   On She woke up and both of her legs were numb, and could not feel her legs from her ankle to her hip/waste area.  When she opened her eyes she thought she was looking at the side wall and was looking at the ceiling and could not discern where she was, was disoriented and called her doctor and told to go to the ER.    She has not been able to return to work as a teacher due to the reaction she has been having.  She wants to know what the efficacy is now that she has had a reaction or has it lessened or does she have any protection at all now.
About 10 minutes after the injection she notice numbness and tingling in the palm of her hand that spread to her fingers. It has started to improve.
As soon as she got the shot she got immediately sick to her stomach, started itching and broke out in a cold sweat. Took Benadryl when she got home and by that evening her tongue and throat started swelling, heart palpitations and couldn't breathe. Went to the ER  blood pressure started going up, heart started racing and was having spasms. When released from ER started getting blisters. Went to Hospital ER.
pt presents to the ED for SOB/nasuea and dizziness that began yesterday evening after receiving the J&J vaccine on 5/6/21.
Itching around site for 2-3 hours, after 5/10/05 injection never reported until came for hep B #3 on 5/23/06 Hep B #3 not given by general HD.
This spontaneous report was received from a Physician Assistant (P.A), concerning an unspecified patient of unknown age and gender. No pertinent medical history, drug reactions, allergies or concurrent conditions were reported. On unspecified date in 2016, the patient was vaccinated with an unspecified expired dose of ZOSTAVAX via subcutaneous route (expiration date of 23-APR-2016) (strength, dose, anatomical location and lot number were not reported). No adverse effects were provided. Concomitant medications were not reported. No product quality complaint (PQC) was involved. Additional information has been requested.
Pt got flu and pneumonia vaccine on 10/13/11. Came back 10/14 (L) arm was red & swollen. Pt complained of stiffness & pain going into her neck. Pt has flu vaccine before, was not sure about pneumo, but probably not. Advised pt. to take BENADRYL & ADVIL and to follow up w/ new symptoms.
Received tdap 0945am 02/25/2022 then received moderna booster at 630pm 02/25/2022. Reports swelling, redness, and pain to 20yo BCG vaccine scar beginning Sunday 02/27/2022. Redness has improved but tenderness to touch, swelling is the same.
I received the Moderna booster shot because my place of work required it. I received the J&J back in May 2021. On the night I received the booster, I had extreme chills and body aches. I woke up the next morning feeling extremely light-headed and foggy. When I went to the bathroom, I passed out and hit my head on the door frame. I woke up on the ground feeling completely out of sorts with a huge welt on my head. I didn't do anything different than a normal day and hydrated and ate dinner the night prior. The EMTs had to come to my house and check me out. I have had a constant headache ever since which is probably a result of the concussion I received after fainting.
I received my Covid -19 vaccine on 01/05/20223. On 1/6/2023 I tested positive for Covid-19. I didn't get sick until two days after. My symptoms were a head cold, headache; Laryngitis; cough. Once I contacted my doctor, I was prescribed Paxlovid. Symptoms lasted a week.
I received my second Moderna booster for COVID-19 on 4/27/2022. On 7/10/2022, I felt an extreme fatigue that I had never experienced before. We had had a busy week and had just returned from a long road trip, so I thought it was probably caused by all the activity. On 7/12/2022, I began coughing and sneezing and still had the aforementioned fatigue. However, I had no fever. I took a PCR test on 7/13/2022, and I got a positive result on 7/14/2022. On 7/15/2022, I called my PCP, who prescribed me a 5-day supply of molnupiravir, which I first took that night. I took a home test for COVID-19 on 7/20/2022 or 7/21/2022, and I got a positive result. I then took another home test on 7/25/2022, and I finally got a negative result. At the time of this writing, I feel fine, though I still have residual fatigue. However, I feel that I'm getting better every day.
I had a fever and sore throat. I had slight cough and stuffy running nose. I also had chills at night. I took some medicine between.
Aproximately 9.5 hours after having my booster, Moderna COVID-19 Vaccine EUA (after Pfizer original two doses), I developed dizziness, nausea, fever, chills, all-over body aches, very sore arm, and tiredness. This lasted throughout the night and all the next day. By the day after that, I was fine. Advil helped a lot.
This spontaneous report was received from a healthcare worker refers to two patient of unknown age. On an unknown date, the patients were vaccinated with improperly stored GARDASIL, (lot number and expiry date was not reported). No adverse effect reported. Additional information has been requested.
pt recvd vax on 25APR85 & exp chronic rubella induced arthritis, resulting in chronic pain in joints & body; No further details were provided;
Pt received Pneumovax in left deltoid later that day pt had swelling at injection site with 2.5X1 inch area.  It appeared as cellulitis.  Pt was treated with Benadryl, ice, heat, antibiotics, and observation.  Pt discharged the next day on oral antibiotics with following up wound care appt with PCP as an outpatient.
Discharge Provider: MD Primary Care Physician at Discharge:  MD Admission Date: 9/28/2022  PRESENTING PROBLEM: Fall, initial encounter [W19.XXXA] Acute hypoxemic respiratory failure (HCC) [J96.01] Acute hypoxemic respiratory failure due to COVID-19 (HCC) [U07.1, J96.01] COVID-19 [U07.1]   HOSPITAL COURSE: Patient is a 77 y.o. female with a PMH of limited scleroderma with CREST syndrome, pulmonary hypertension, restrictive lung disease, AFib on Xarelto, combined systolic and diastolic heart failure who presented to the ED 9/28/22 with altered mental status and weakness. She had experienced a ground level unwitnessed fall 9/27/22 and was evaluated at ED and was able to retturn ot home where she was living with her spouse. While advanced imaging did not demonstrate acute pathology, family reports patient became progressively weak and tired with altered mentation. They decided to present to ED as she was lethargic and no longer able to ambulate.    Vital signs notable for BP 99/62, HR 150, SpO2 77% and temp 38.7 C. A nonrebreather was placed with SpO2's remaining in the 70% range. Was then escalated to HFNC at 50 L/min which improved oxygenation to 80's. SpO2 increased to max of 88%. ABG revealed pH of 7.4 CO2 of 34 and PO2 of 61. Patient was not considered a candidate for bipap due to mental status. Labs notable for CMP with BUN 32, creatinine 1.49, AST 55, troponin 87 with delta -17 on repeat, BNP 29,942, TSH 5.75, lactic acid 4.3 with interval improvement to 2.7, positive COVID-PCR. Chest XR demonstrated small amount of patchy atelectasis or pneumonitis in the RUL. CT head and neck w/o contrast without acute abnormality. CT cervical, thorax and lumbar spine without acute findings. CT t/a/p demonstrates no acute abnormality in the chest, abdomen or pelvis but demonstrated biatrial enlargement and bronchitis. EKG demonstrated Afib with RVR which was treated with one dose of metoprolol with improved heart rate and blood pressure. Patient was given 2 L of fluids and started on Zosyn due to concern for infectious etiology. She was also given a dose of decadron. With the development of these findings and worsening clinical condition of the patient, family decided to pursue comfort care and avoid invasive diagnostic testing. Patient was admitted for acute hypoxic respiratory failure with the goal of arranging home hospice services.    Shortly after arriving to the admitting floor,  was transitioned to non-rebreather for comfort overnight. The morning of 9/29, patient's family wished to further transition to nasal cannula to improve comfort. Palliative care was consulted as well as chaplain services. Palliative care team assisted with connecting with home with hopes of having hospice services arranged to be able to take patient home in 1-2 days. While logistics were being arranged, patient's comfort continued to be optimized. Multiple family members were able to visit 9/29/22. Family went home the evening of 9/29 and patient passed away the morning of 9/30/22.    Date of Death: 9/30/22 Time of Death:  7:01 AM Preliminary Cause of Death: Respiratory failure with hypoxia (HCC)
idiopathic thrombocytopenic purpura had similar reactin with 1st MMR at 15 months.
very tired/very fatigued; nauseated; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non-HCP) from medical information team. The reporter is the patient.  A 91-years-old male patient received bnt162b2 (BNT162B2), administration date Oct2021 (Batch/Lot number: unknown) as DOSE 3 (BOOSTER), SINGLE for covid-19 immunization. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Bnt162b2 (DOSE 1, SINGLE), for COVID-19 immunization; Bnt162b2 (DOSE 2, SINGLE), for COVID-19 immunization. The following information was reported: FATIGUE (non-serious), outcome "unknown", described as "very tired"; NAUSEA (non-serious), outcome "unknown", described as "nauseated"; FATIGUE (non-serious), outcome "unknown", described as "very fatigued".  Additional Information: Caller stated this was the fourth time he had tried to speak with someone and he was age 91-years-old and received the booster shot a week ago and both were very tired and he was nauseated and he wants to know how long the side effects will last.  QR Comment: Reporter type could not be probed as consumer hung up the call abruptly, hence reporter type captured as consumer or non-healthcare professional by default. AE filed conservatively.  No follow-up attempts are possible. No further information is expected.; Sender's Comments: Linked Report(s) : US-PFIZER INC-202101368567 Same drug/AE, different patient
Rash over legs, back, and arms; very itchy;  hives on back and legs
Product storage error/freezer went to -10.5 C for 24 minutes; no adverse event; Doses were administered after the excursion happened on 15Nov2022; This spontaneous case was reported by an other health care professional and describes the occurrence of PRODUCT TEMPERATURE EXCURSION ISSUE (Doses were administered after the excursion happened on 15Nov2022), PRODUCT STORAGE ERROR (Product storage error/freezer went to -10.5 C for 24 minutes) and NO ADVERSE EVENT (no adverse event) in an adult patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 017B22A) for COVID-19 prophylaxis.     No Medical History information was reported.    On 15-Nov-2022, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 15-Nov-2022, the patient experienced PRODUCT TEMPERATURE EXCURSION ISSUE (Doses were administered after the excursion happened on 15Nov2022). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (Product storage error/freezer went to -10.5 C for 24 minutes) and NO ADVERSE EVENT (no adverse event). At the time of the report, PRODUCT TEMPERATURE EXCURSION ISSUE (Doses were administered after the excursion happened on 15Nov2022), PRODUCT STORAGE ERROR (Product storage error/freezer went to -10.5 C for 24 minutes) and NO ADVERSE EVENT (no adverse event) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter considered NO ADVERSE EVENT (no adverse event) to be not related. No further causality assessments were provided for PRODUCT TEMPERATURE EXCURSION ISSUE (Doses were administered after the excursion happened on 15Nov2022) and PRODUCT STORAGE ERROR (Product storage error/freezer went to -10.5 C for 24 minutes).    No concomitant medication was reported. It was reported that for the Moderna monovalent vaccine, Max temp: -10.5 C (no breakdown available) was reached. It took 24 minutes to get back down to normal range. The medical assistant has data logs. No treatment medication was reported.   This case was linked to US-MODERNATX, INC.-MOD-2022-685555 (Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2022-685555:same reporter
Patient woke up the next morning 10/5/17 with chills and fever. She called an RN and was instructed to go to the ER. She presented to the ER with fever and what looked like an infection. She was placed on IV antibiotics and was released the next day. Patient was also placed on Ciprofloxacin for 6 days.
Patient felt "unwell", then seven days later, no appetite, fever, fatigue and chills.
Patient was given the Td vaccine on 6/4/08, prior to his leaving work.  He returned to the clinic on 6/5/08 complaining of redness,pain and swelling to the injection site.  Had a "golf ball" size red area at the site of the injection. At the close of his shift the red area had increase to baseball size.  Was sent to the local clinic and given antibiotics and benadryl.  Next seen 6/9/08 and reaction has resolved.  No residual soreness.
No additional AE reported; HCP reported PROQUAD was administered to patient after a temperature excursion. Date of administration was Mar 23, 2022. No further information provided. This is patient one of three, cross reference AE cases: 02202238 and 02202256. No additional AE; This spontaneous report was received from a nurse and refers to a patient of unknown age and gender.  The patient's medical history, concurrent conditions, concomitant medications and drug reactions/ allergies were not reported.  On 23-MAR-2022, the patient was vaccinated with an improperly stored (-8.3 Celsius degrees, time frame: 1 hour, 1 minute and 0 seconds) measles, mumps, rubella and varicella (oka-merck) virus vaccine live, recombinant human albumin (rHA) (PROQUAD) subcutaneous injection, once, lot number U029320 was found to be valid, expiration date: 19-MAR-2023 (strength, exact dose, route of administration and injection site were not reported) for prophylaxis (product storage error). No additional adverse events were reported.  This is one of several reports received from the same reporter.; Sender's Comments:  US-009507513-2207USA003330: US-009507513-2207USA003487:
On 5/14/21 Patient received 2nd dose of COVID Moderna vaccine at 21 days after the 1st dose given on 4/23/21.
swelling of windpipe and lips; hives; swelling of the eyes; swelling of windpipe and lips; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP) from a sales representative.  A female patient received BNT162b2, BNT162b2 omi ba.4-5 (BNT162B2, BNT162B2 OMI BA.4-5), as dose number unknown (booster), single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history included: lsaacs disease (unspecified if ongoing), notes: lsaacs disease; BP (unspecified if ongoing). The patient took concomitant medications. Vaccination history included: Covid-19 vaccine (Primary Immunization series complete;  unknown manufacturer), for COVID-19 immunization. The following information was reported: TRACHEAL INFLAMMATION (hospitalization), LIP SWELLING (hospitalization), outcome "unknown" and all described as "swelling of windpipe and lips"; URTICARIA (hospitalization), outcome "unknown", described as "hives"; EYE SWELLING (hospitalization), outcome "unknown", described as "swelling of the eyes". The patient was hospitalized for lip swelling, eye swelling (hospitalization duration: 2 day(s)).  Clinical information: In middle of night, patient experienced swelling of windpipe and lips. The second day she had hives and swelling of the eyes. Had to be hospitalized for 2 days. Optional Information includes lsaacs disease, was on 2 BP meds. Event took place after use of product.  The information on the batch/lot number for BNT162b2, BNT162b2 omi ba.4-5 has been requested and will be submitted if and when received.
Headache; Fatigue / Tiredness; Nausea; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) for a sponsored program (159558).  A 80 year-old female patient received bnt162b2 (BNT162B2), intramuscular, administration date 28Jan2021 10:00 (Lot number: EL9263, Expiration Date: 31May2021) at the age of 80 years as dose 1, single for covid-19 immunisation. Relevant medical history included: "Short of breath", start date: 12Jan2021 (ongoing). The patient's concomitant medications were not reported. The following information was reported: HEADACHE (non-serious) with onset 28Jan2021, outcome "unknown", described as "Headache"; FATIGUE (non-serious) with onset 28Jan2021, outcome "unknown", described as "Fatigue / Tiredness"; NAUSEA (non-serious) with onset 28Jan2021, outcome "unknown", described as "Nausea". Relevant laboratory tests and procedures are available in the appropriate section.  No follow-up attempts are possible. No further information is expected.; Sender's Comments: Linked Report(s) : US-PFIZER INC-2021762946 same patient, vaccine, events; different dose
Extreme fever 6 hours following the shot. Fatigue lasted roughly 48 hours. Then Sunday 4/11, 5 days after receiving the shot, I've experienced shortness of breath. It felt like someone was sitting on my chest. This restriction has loosened since but still causes discomfort.
Swollen and painful left armpit; Painful left armpit; Swollen and painful left armpit/lymph node; Painful left armpit/lymph node; The patient received third/booster dose of BNT162b2; This is a spontaneous report from a contactable reporter (Consumer or other non HCP). The reporter is the patient.  A 49-year-old female patient (not pregnant) received bnt162b2 (BNT162B2), administered in left arm, administration date 02Dec2021 at 11:15 (Lot number: unknown) at the age of 49 years as dose 3 (booster), single for COVID-19 immunisation. Relevant medical history included: "Hashimoto's thyroiditis" (unspecified if ongoing). Concomitant medications included: SYNTHROID. Vaccination history included: Bnt162b2 (DOSE 2, SINGLE, Lot number: UNKNOWN, Anatomical location: Left arm), administration date: 15Mar2021, when the patient was 48 years old, and Bnt162b2 (DOSE 1, SINGLE, Lot number: UNKNOWN, Anatomical location: Left arm), administration date: 22Feb2021, when the patient was 48 years old, for COVID-19 immunisation.  The following information was reported: IMMUNISATION (non-serious) with onset 02Dec2021 at 11:15, outcome "unknown", described as "The patient received third/booster dose of BNT162b2"; SWELLING (non-serious) with onset 03Dec2021 at 08:00, outcome "recovering", described as "Swollen and painful left armpit"; AXILLARY PAIN (non-serious) with onset 03Dec2021 at 08:00, outcome "recovering", described as "Painful left armpit"; LYMPHADENOPATHY (non-serious) with onset 03Dec2021 at 08:00, outcome "recovering", described as "Swollen and painful left armpit/lymph node"; LYMPH NODE PAIN (non-serious) with onset 03Dec2021 at 08:00, outcome "recovering", described as "Painful left armpit/lymph node". Therapeutic measures were taken as a result of swelling, axillary pain, lymphadenopathy and lymph node pain.  Additional information: The patient had no known allergies. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Treatment included advil for swelling, axillary pain, lymphadenopathy and lymph node pain.  The lot number for BNT162b2 was not provided and will be requested during follow up.
10/30 - seen for fever of 102 and 1 week of cough told post vaccine fever. 10/31 - seen for fever, worse sxs and cough, mom reports to walk in provider he was sick x 2 weeks.
5NOV96 pt recv vax about 3hr later c/o feet burning;hives noticed 10hr p/vax all over trunk & limbs;no joint swelling, no resp problems;given DPH sx relief of itching;
Information has been received from a physician concerning a 16 year old male who on 18-OCT-1994 and 01-OCT-1998 was vaccinated with the first and the second doses of MMR II (lot# not reported) respectively. On 29-NOV-2009, the patient was diagnosed and was afebrile. On 22-DEC-2009 the patient experienced mumps. The patient was afebrile. Parotitis was on the right and the count was 108. It was unspecified if the patient sought medical attention. In follow-up, the physician indicated that on 19-JAN-2010 the patient developed mumps. On 20-JAN-2010 the patient was diagnosed. The patient had a fever of 101 degrees F. Parotitis was on the left. Other symptoms included gland afebrile. The first blood work on 20-JAN-2010 revealed serum IgM (immunoglobulin M) <1:10, serum IgG (immunoglobulin G) 7.09, and serum amylase 349. Additional information has been requested.
10-13-07 1130 received flu vaccine right deltoid. 10-14-07 23 hours later awakened with pain and swelling from injection and into armpit. Patient applied heat to armpit and deltoid, swelling decreased only to increase when heat was removed. Unable to use right arm from 10-14-07 to 10-16-07. Missing work 10-15-07. 10-16-07 Unable to raise arm to shoulder height. Unable to lift weight with right arm. Deltoid and armpit still swollen 10-16-07 but decreased.